LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 107

Search options

  1. Article ; Online: Seizures in autoimmune-associated epilepsy: a long-term video-EEG monitoring study.

    Fonte, Joana / Stabile, Andrea / de Curtis, Marco / Di Giacomo, Roberta / Pastori, Chiara / Didato, Giuseppe / Andreetta, Francesca / Del Sole, Angelo / Doniselli, Fabio / Deleo, Francesco

    Journal of neurology

    2024  

    Language English
    Publishing date 2024-04-24
    Publishing country Germany
    Document type Letter
    ZDB-ID 187050-6
    ISSN 1432-1459 ; 0340-5354 ; 0012-1037 ; 0939-1517 ; 1619-800X
    ISSN (online) 1432-1459
    ISSN 0340-5354 ; 0012-1037 ; 0939-1517 ; 1619-800X
    DOI 10.1007/s00415-024-12385-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Bucci, Tommaso / Del Sole, Francesco / Menichelli, Danilo / Galardo, Gioacchino / Biccirè, Flavio Giuseppe / Farcomeni, Alessio / Lip, Gregory Y H / Pignatelli, Pasquale / Pastori, Daniele

    Journal of clinical medicine

    2024  Volume 13, Issue 7

    Abstract: ... ...

    Abstract Objectives
    Language English
    Publishing date 2024-03-31
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13072033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Atmospheric Pressure Plasma Deposition of Hybrid Nanocomposite Coatings Containing TiO

    Del Sole, Regina / Lo Porto, Chiara / Lotito, Sara / Ingrosso, Chiara / Comparelli, Roberto / Curri, Maria Lucia / Barucca, Gianni / Fracassi, Francesco / Palumbo, Fabio / Milella, Antonella

    Molecules (Basel, Switzerland)

    2023  Volume 28, Issue 13

    Abstract: Among the different applications of ... ...

    Abstract Among the different applications of TiO
    MeSH term(s) Carbon ; Spectroscopy, Fourier Transform Infrared ; Titanium/chemistry ; Nanocomposites/chemistry ; Methylene Blue/chemistry ; Catalysis
    Chemical Substances graphene oxide ; titanium dioxide (15FIX9V2JP) ; Carbon (7440-44-0) ; Titanium (D1JT611TNE) ; Methylene Blue (T42P99266K)
    Language English
    Publishing date 2023-06-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules28135131
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Risk of venous thromboembolism in autoimmune diseases: A comprehensive review.

    Menichelli, Danilo / Cormaci, Vito Maria / Marucci, Silvia / Franchino, Giovanni / Del Sole, Francesco / Capozza, Alessandro / Fallarino, Alessia / Valeriani, Emanuele / Violi, Francesco / Pignatelli, Pasquale / Pastori, Daniele

    Autoimmunity reviews

    2023  Volume 22, Issue 11, Page(s) 103447

    Abstract: Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of the disease, and to concomitant treatments. ... ...

    Abstract Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of the disease, and to concomitant treatments. In this review, we revise the most common autoimmune disease such as antiphospholipid syndrome, inflammatory myositis, polymyositis and dermatomyositis, rheumatoid arthritis, sarcoidosis, Sjogren syndrome, autoimmune haemolytic anaemia, systemic lupus erythematosus, systemic sclerosis, vasculitis and inflammatory bowel disease. We also provide an overview of pathophysiology responsible for the risk of VTE in each autoimmune disorder, and report current indications to anticoagulant treatment for primary and secondary prevention of VTE.
    MeSH term(s) Humans ; Venous Thromboembolism/complications ; Venous Thromboembolism/epidemiology ; Autoimmune Diseases/complications ; Autoimmune Diseases/epidemiology ; Arthritis, Rheumatoid/complications ; Antiphospholipid Syndrome/complications ; Lupus Erythematosus, Systemic/complications
    Language English
    Publishing date 2023-09-14
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2023.103447
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.

    Scarsini, Roberto / Portolan, Leonardo / Della Mora, Francesco / Fabroni, Margherita / Andreaggi, Stefano / Mainardi, Andrea / Springhetti, Paolo / Dotto, Alberto / Del Sole, Paolo Alberto / Fezzi, Simone / Pazzi, Sara / Tavella, Domenico / Mammone, Concetta / Lunardi, Mattia / Pesarini, Gabriele / Benfari, Giovanni / Ribichini, Flavio Luciano

    Heart (British Cardiac Society)

    2024  Volume 110, Issue 8, Page(s) 603–612

    Abstract: Objectives: This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD). ... ...

    Abstract Objectives: This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD). Moreover, we sought to test the correlation between angiography-derived index of microcirculatory resistance (IMR
    Methods: This was a retrospective analysis of the Verona Valvular Heart Disease Registry (Italy) including 250 patients (83 (80-86) years, 53% female) with severe AS who underwent TAVI between 2019 and 2021. IMR
    Results: The primary endpoint occurred in 28 (11.2%) patients at a median follow-up of 22 (IQR 12-30) months. Patients with CMD met the primary endpoint more frequently than those without CMD (22.9% vs 2.8%, p<0.0001). Patients with CMD were more frequently characterised by advanced EVCD (33 (31.4%) vs 27 (18.6%), p=0.024). CMD was an independent predictor of adverse outcomes (adjusted HR 6.672 (2.251 to 19.778), p=0.001) and provided incremental prognostic value compared with conventional clinical and imaging variables. IMR
    Conclusions: CMD is an independent predictor of cardiovascular mortality and HF after TAVI.
    MeSH term(s) Humans ; Female ; Male ; Transcatheter Aortic Valve Replacement/adverse effects ; Retrospective Studies ; Microcirculation ; Treatment Outcome ; Aortic Valve Stenosis/complications ; Aortic Valve Stenosis/surgery ; Myocardial Ischemia ; Aortic Valve/surgery
    Language English
    Publishing date 2024-03-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1303417-0
    ISSN 1468-201X ; 1355-6037
    ISSN (online) 1468-201X
    ISSN 1355-6037
    DOI 10.1136/heartjnl-2023-323461
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.

    Pastori, Daniele / Menichelli, Danilo / Del Sole, Francesco / Pignatelli, Pasquale / Violi, Francesco

    Mayo Clinic proceedings

    2020  Volume 96, Issue 3, Page(s) 658–665

    Abstract: Objective: To determine the association between direct oral anticoagulant (DOAC) use and risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF).: Patients and methods: This study is a single-center prospective ... ...

    Abstract Objective: To determine the association between direct oral anticoagulant (DOAC) use and risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF).
    Patients and methods: This study is a single-center prospective observational cohort study including 2366 outpatients with non-valvular AF on treatment with DOACs or vitamin K antagonists (VKAs) from February 2008 for patients on VKA and September 2013 for patients on novel oral anticoagulants. The primary endpoint was the incidence of MACE including fatal and non-fatal myocardial infarction (MI), cardiac revascularization, and cardiovascular death.
    Results: The mean age was 75.1±9.0 years; 44.7% were women. During a mean follow-up of 33.3±21.9 months (6567 patients/years) 133 MACEs occurred (2.03%/year): 79 MI/cardiac revascularization and 54 cardiovascular deaths. Of these, 101 were on VKAs (2.42%/year) and 32 on DOACs (1.34%/year; log-rank test P=.040). This difference was evident also considering MI alone (1.53%/year and 0.63%/year in the VKA and DOAC group, respectively, log-rank test P=.009). At multivariable Cox proportional hazard regression analysis, use of DOACs was associated with a lower risk of MACE (hazard ratio, 0.636; 95% CI, 0.417 to 0.970; P=.036) and MI (hazard ratio, 0.497; 95% CI, 0.276 to 0.896; p=.020). Sensitivity analysis showed that this association was consistent in younger patients (<75 years), in patients with anemia, and in those without chronic obstructive pulmonary disease and heart failure. We also found that both dabigatran and apixaban/rivaroxaban were associated with a lower rate of MACE, with similar efficacy between full and low doses.
    Conclusion: DOACs are associated with a lower risk of MACE in patients with AF independently from dosage.
    MeSH term(s) Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/therapeutic use ; Atrial Fibrillation/drug therapy ; Cohort Studies ; Dabigatran/therapeutic use ; Female ; Heart Failure/drug therapy ; Humans ; Male ; Medication Adherence/statistics & numerical data ; Middle Aged ; Myocardial Infarction/drug therapy ; Platelet Aggregation Inhibitors/therapeutic use ; Prospective Studies ; Rivaroxaban/therapeutic use
    Chemical Substances Anticoagulants ; Platelet Aggregation Inhibitors ; Rivaroxaban (9NDF7JZ4M3) ; Dabigatran (I0VM4M70GC)
    Language English
    Publishing date 2020-12-09
    Publishing country England
    Document type Journal Article ; Observational Study
    ZDB-ID 124027-4
    ISSN 1942-5546 ; 0025-6196
    ISSN (online) 1942-5546
    ISSN 0025-6196
    DOI 10.1016/j.mayocp.2020.06.057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology.

    Pastori, Daniele / Cormaci, Vito Maria / Marucci, Silvia / Franchino, Giovanni / Del Sole, Francesco / Capozza, Alessandro / Fallarino, Alessia / Corso, Chiara / Valeriani, Emanuele / Menichelli, Danilo / Pignatelli, Pasquale

    International journal of molecular sciences

    2023  Volume 24, Issue 4

    Abstract: Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies according to different countries, ranging from 1-2 per 1000 person-years in Western Countries, while it is lower in Eastern Countries (<1 per 1000 ...

    Abstract Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies according to different countries, ranging from 1-2 per 1000 person-years in Western Countries, while it is lower in Eastern Countries (<1 per 1000 person-years). Many risk factors have been identified in patients developing VTE, but the relative contribution of each risk factor to thrombotic risk, as well as pathogenetic mechanisms, have not been fully described. Herewith, we provide a comprehensive review of the most common risk factors for VTE, including male sex, diabetes, obesity, smoking, Factor V Leiden, Prothrombin G20210A Gene Mutation, Plasminogen Activator Inhibitor-1, oral contraceptives and hormonal replacement, long-haul flight, residual venous thrombosis, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, trauma and fractures, pregnancy, immobilization, antiphospholipid syndrome, surgery and cancer. Regarding the latter, the incidence of VTE seems highest in pancreatic, liver and non-small cells lung cancer (>70 per 1000 person-years) and lowest in breast, melanoma and prostate cancer (<20 per 1000 person-years). In this comprehensive review, we summarized the prevalence of different risk factors for VTE and the potential molecular mechanisms/pathogenetic mediators leading to VTE.
    MeSH term(s) Female ; Humans ; Male ; Venous Thromboembolism/genetics ; COVID-19 ; SARS-CoV-2 ; Risk Factors ; Venous Thrombosis/genetics ; Thrombophilia/genetics
    Language English
    Publishing date 2023-02-05
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24043169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis.

    Pastori, Daniele / Farcomeni, Alessio / Milanese, Alberto / Del Sole, Francesco / Menichelli, Danilo / Hiatt, William R / Violi, Francesco

    Thrombosis and haemostasis

    2020  Volume 120, Issue 5, Page(s) 866–875

    Abstract: Background:  Statins are guidelines recommended in patients with peripheral artery disease (PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the impact of statins on major adverse limb events (MALE) in PAD patients are ... ...

    Abstract Background:  Statins are guidelines recommended in patients with peripheral artery disease (PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the impact of statins on major adverse limb events (MALE) in PAD patients are lacking. We examined the association of statin use with MALE in patients with PAD.
    Methods:  We performed a systematic review (registered at PROSPERO: number CRD42019137111) and metanalysis of studies retrieved from PubMed (via MEDLINE) and Cochrane (CENTRAL) databases addressing the impact of statin on MALE including amputation and graft occlusion/revascularization. Secondary endpoints were all-cause death, composite CV endpoints, CV death, and stroke.
    Results:  We included 51 studies with 138,060 PAD patients, of whom 48,459 (35.1%) were treated with statins. The analysis included 2 randomized controlled trials, 20 prospective, and 29 retrospective studies. Overall, 11,396 MALE events, 21,624 deaths, 4,852 composite CV endpoints, 4,609 CV deaths, and 860 strokes were used for the analysis. Statins reduced MALE incidence by 30% (pooled hazard ratio [HR]: 0.702; 95% confidence interval [CI]: 0.605-0.815) and amputations by 35% (HR: 0.654; 95% CI: 0.522-0.819), all-cause mortality by 39% (pooled HR: 0.608, 95% CI: 0.543-0.680), CV death by 41% (HR: 0.594; 95% CI: 0.455-0.777), composite CV endpoints by 34% (pooled HR: 0.662; 95% CI: 0.591-0.741) and ischemic stroke by 28% (pooled HR: 0.718; 95% CI: 0.620-0.831).
    Conclusion:  Statins reduce the incidence of MALE, all-cause, and CV mortality in patients with PAD. In PAD, a high proportion of MALE events and deaths could be prevented by implementing a statin prescription in this patient population.
    MeSH term(s) Amputation ; Cause of Death ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Incidence ; Limb Salvage ; Peripheral Arterial Disease/diagnosis ; Peripheral Arterial Disease/epidemiology ; Peripheral Arterial Disease/mortality ; Peripheral Arterial Disease/therapy ; Risk Assessment ; Risk Factors ; Treatment Outcome ; Vascular Surgical Procedures/adverse effects ; Vascular Surgical Procedures/mortality
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2020-05-05
    Publishing country Germany
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1055/s-0040-1709711
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.

    Menichelli, Danilo / Sciacqua, Angela / Cangemi, Roberto / Andreozzi, Paola / Del Sole, Francesco / Violi, Francesco / Pignatelli, Pasquale / Pastori, Daniele

    International journal of clinical practice

    2020  Volume 75, Issue 3, Page(s) e13771

    Abstract: Background: There are conflicting evidence on the association between atrial fibrillation (AF) pattern, such as persistent/permanent (Pers/Perm) and paroxysmal (PAF) AF and risk of ischemic events. We investigated if left atrial diameter (LAd) may ... ...

    Abstract Background: There are conflicting evidence on the association between atrial fibrillation (AF) pattern, such as persistent/permanent (Pers/Perm) and paroxysmal (PAF) AF and risk of ischemic events. We investigated if left atrial diameter (LAd) may affect the risk of cardiovascular outcomes according to AF pattern.
    Methods: Prospective multicenter observational including 1,252 non-valvular AF patients (533 PAF and 719 Pers/Perm AF). Study endpoints were cardiovascular events (CVEs), major adverse cardiac events (MACE) and CV death. LA anteroposterior diameter (LAd) was obtained by transthoracic echocardiography.
    Results: Pers/Perm AF patients had a higher proportion of LAd above median than PAF (≥44 mm, 59.5% vs 37.5% respectively, P < .001). In a mean follow-up of 42.2 ± 31.0 months (4,315 patients/year) 179 CVEs (incidence rate [IR] 4.2%/year), 133 MACE (IR 3.1%/year), and 97 CV deaths (IR 2.2%/year) occurred. Compared to patients with LAd below median, those with LAd above the median had a higher rate of CVEs (log-rank test, P < .001), MACE (log-rank test P < .001), and CV death (log-rank test P < .001). Multivariable Cox regression analysis showed that LAd above the median was associated with CVEs, (HR 1.569, 95% CI 1.129-2.180, P = .007) MACE (HR 1.858, 95% CI 1.257-2.745, P = .002) and CV death (HR 2.106, 95% CI 1.308-3.390, P = .002). The association between LAd and outcomes was evident both in PAF and Pers/Perm AF patients. No association between AF pattern and outcomes was found.
    Conclusion: LAd is a simple parameter that can be obtained in virtually all AF patients and can provide prognostic information on the risk of CVEs, MACE and CV death regardless of AF pattern.
    MeSH term(s) Atrial Fibrillation/complications ; Echocardiography ; Heart Atria/diagnostic imaging ; Humans ; Incidence ; Prospective Studies ; Risk Factors
    Language English
    Publishing date 2020-11-09
    Publishing country India
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 1386246-7
    ISSN 1742-1241 ; 1368-5031
    ISSN (online) 1742-1241
    ISSN 1368-5031
    DOI 10.1111/ijcp.13771
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Atmospheric Pressure Plasma Deposition of Hybrid Nanocomposite Coatings Containing TiO 2 and Carbon-Based Nanomaterials

    Regina Del Sole / Chiara Lo Porto / Sara Lotito / Chiara Ingrosso / Roberto Comparelli / Maria Lucia Curri / Gianni Barucca / Francesco Fracassi / Fabio Palumbo / Antonella Milella

    Molecules, Vol 28, Iss 5131, p

    2023  Volume 5131

    Abstract: Among the different applications of TiO 2 , its use for the photocatalytic abatement of organic pollutants has been demonstrated particularly relevant. However, the wide band gap (3.2 eV), which requires UV irradiation for activation, and the fast ... ...

    Abstract Among the different applications of TiO 2 , its use for the photocatalytic abatement of organic pollutants has been demonstrated particularly relevant. However, the wide band gap (3.2 eV), which requires UV irradiation for activation, and the fast electron-hole recombination rate of this n-type semiconductor limit its photocatalytic performance. A strategy to overcome these limitations relies on the realization of a nanocomposite that combines TiO 2 nanoparticles with carbon-based nanomaterials, such as rGO (reduced graphene oxide) and fullerene (C 60 ). On the other hand, the design and realization of coatings formed of such TiO 2 -based nanocomposite coatings are essential to make them suitable for their technological applications, including those in the environmental field. In this work, aerosol-assisted atmospheric pressure plasma deposition of nanocomposite coatings containing both TiO 2 nanoparticles and carbon-based nanomaterials, as rGO or C 60 , in a siloxane matrix is reported. The chemical composition and morphology of the deposited films were investigated for the different types of prepared nanocomposites by means of FT-IR, FEG-SEM, and TEM analyses. The photocatalytic activity of the nanocomposite coatings was evaluated through monitoring the photodegradation of methylene blue (MB) as a model organic pollutant. Results demonstrate that the nanocomposite coatings embedding rGO or C 60 show enhanced photocatalytic performance with respect to the TiO 2 counterpart. In particular, TiO 2 /C 60 nanocomposites allow to achieve 85% MB degradation upon 180 min of UV irradiation.
    Keywords plasma deposition ; nanocomposite coating ; TiO 2 ; photocatalysis ; aerosol-assisted plasma ; carbon nanomaterials ; Organic chemistry ; QD241-441
    Subject code 620
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top